Research Division
The Second Annual Collaborative Research and Innovation Symposium, co-hosted by NHS Fife and the University of St Andrews, took place on Wednesday, 25 October. Held at the Balbirnie House Hotel in Markinch, the event…
The Arclight Project team has had a busy few months of presentations, workshops, and grant success! In August, Dr Blaikie presented a scientific paper on telemedicine and delivered a seminar on medical education at the…
A new study led by Principal Research Fellow Dr Wilber Sabiiti has found that antibiotics used to treat tuberculosis also kill other potentially useful bacteria. Such “good” bacteria play a key role in strengthening…
This summer, the Division of Infection and Global Health was privileged to host Professor Kwabena Duedu, Associate Professor of Biomedical Science at the University of Health and Allied Sciences (UHAS). This visit was…
On 4 August, Principal Research Fellow Dr Wilber Sabiiti attended the launch of the BREEDIME project in Dar es Salaam, Tanzania. As a project partner, the University will support work on training, in vitro diagnostics…
Principal Research Fellow Dr Wilber Sabiiti has had a busy spring and summer of working with the ASCEND project to advance Tanzania’s research ethics infrastructure and medicine-regulation capacity. The ASCEND project,…
Principal Research Fellow Dr Wilber Sabiiti spent much of March and April this year on the road, educating fellow researchers about a novel tuberculosis (TB) test developed by the School’s Infection and Global Health…
A new study led by MD student and cardiologist Dr Alexander Liu may have significant implications for COVID-19 risk stratification. This practice involves identifying populations who are more or less at risk of…
A new study published in Globalization and Health and led by the School of Medicine has highlighted the role corporate tax revenue can play in achieving the United Nations’ sustainable development goals (SDGs).…
World-leading scientists from the Infection and Global Health Division reveal a new Tuberculosis (TB) drug that will shorten the treatment of the disease by up to 2 months, potentially saving millions of lives. Dr Muge…